Recently, we have shown the great potential of TFF1 expression downregulation, one of the genes epigenetically deregulated, as an early ESCC detection biomarker, since it takes place in the tumor-surrounding tissue from ESCC patients, preceding the first morphological and genetic alterations (22). This evidence concerns the gene TFF1 and esophageal squamous cell carcinoma.